Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007860
Filing Date
2022-05-05
Accepted
2022-05-05 16:25:11
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cdak-20220331.htm   iXBRL 10-Q 1978557
2 EX-31.1 cdak-ex31_1.htm EX-31.1 20883
3 EX-31.2 cdak-ex31_2.htm EX-31.2 21558
4 EX-32.1 cdak-ex32_1.htm EX-32.1 23989
  Complete submission text file 0000950170-22-007860.txt   8588901

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdak-20220331_pre.xml EX-101.PRE 422083
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdak-20220331.xsd EX-101.SCH 87989
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdak-20220331_lab.xml EX-101.LAB 608515
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdak-20220331_cal.xml EX-101.CAL 54700
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdak-20220331_def.xml EX-101.DEF 259320
63 EXTRACTED XBRL INSTANCE DOCUMENT cdak-20220331_htm.xml XML 1527133
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39615 | Film No.: 22896737
SIC: 2836 Biological Products, (No Diagnostic Substances)